Author

M. L. Torgersen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. D. Pandya· 1 shared A. Watts· 1 shared C. Raiborg· 1 shared C. W. Davies· 1 shared D. J. Yin· 1 shared E. Ikonen· 1 shared E. M. Wenzel· 1 shared G. M. Maelandsmo· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. D. Pandya

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ATPase activity of DFCP1 controls selective autophagy

V. Nähse, C. Raiborg, K. W. Tan, S. Mørk, M. L. Torgersen, E. M. Wenzel, M. Nager, V. T. Salo, T. Johansen, E. Ikonen, K. O. Schink, H. Stenmark

This study identifies DFCP1 as an ATPase essential for omegasome constriction and selective autophagy by facilitating autophagosome release.

bioRxiv · Feb 24, 2022Cell Biology

Physicochemical characterization, toxicity and in vivo biodistribution studies of a discoidal, lipid-based drug delivery vehicle: Lipodisq nanoparticles containing doxorubicin

M. L. Torgersen, P. J. Judge, J. F. Bada Juarez, A. D. Pandya, M. Fusser, C. W. Davies, M. K. Maciejewska, D. J. Yin, G. M. Maelandsmo, T. Skotland, A. Watts, K. Sandvig

This paper evaluates Lipodisq nanoparticles as drug delivery vehicles, showing their cytotoxicity and in vivo biodistribution of doxorubicin and their components.

bioRxiv · Jun 18, 2020Pharmacology & Toxicology